Organigram Closes Third Tranche of BAT Private Placement Investment
Generated by AI AgentHarrison Brooks
Monday, Mar 3, 2025 6:05 am ET1min read
DE--
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of cannabis, has announced the closure of the third and final tranche of its previously announced C$124.6 million private placement investment by BT DEDE-- Investments Inc., a wholly-owned subsidiary of British American Tobacco plc (BAT). This strategic investment, which totals C$41.5 million, will be used to fund Organigram's "Jupiter" strategic investment pool, focusing on international expansion, technological advancements, and product innovation.
The closure of the third tranche of BAT's investment in Organigram is a significant development for the latter's financial position and strategic growth plans. The investment, which totals C$124.6 million, will be used to fund a strategic investment pool named "Jupiter," which is designed to accelerate Organigram's international growth ambitions. The Jupiter Pool targets investments both overseas and in the United States, with rigorous legal compliance processes. Following the closing of the first tranche on January 23, 2024, Organigram has already made two significant investments from the Jupiter Pool: USD $2 million in Open Book Extracts (OBX) and €14 million in Sanity Group GmbH.
These investments demonstrate Organigram's commitment to expanding its global footprint and diversifying its revenue streams. With the closure of the third tranche, Organigram will have access to additional capital, which will enable it to continue pursuing strategic investments and international expansion opportunities. This, in turn, is expected to drive revenue growth and create long-term value for shareholders.
The investment in the "Jupiter" strategic investment pool aligns with Organigram's long-term growth strategy by focusing on international expansion, technological advancements, and product innovation. The strategic investments facilitated by the Jupiter pool support Organigram's long-term growth strategy by diversifying its revenue streams, expanding its market reach, and driving innovation in the cannabis industry.
OGI--
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of cannabis, has announced the closure of the third and final tranche of its previously announced C$124.6 million private placement investment by BT DEDE-- Investments Inc., a wholly-owned subsidiary of British American Tobacco plc (BAT). This strategic investment, which totals C$41.5 million, will be used to fund Organigram's "Jupiter" strategic investment pool, focusing on international expansion, technological advancements, and product innovation.
The closure of the third tranche of BAT's investment in Organigram is a significant development for the latter's financial position and strategic growth plans. The investment, which totals C$124.6 million, will be used to fund a strategic investment pool named "Jupiter," which is designed to accelerate Organigram's international growth ambitions. The Jupiter Pool targets investments both overseas and in the United States, with rigorous legal compliance processes. Following the closing of the first tranche on January 23, 2024, Organigram has already made two significant investments from the Jupiter Pool: USD $2 million in Open Book Extracts (OBX) and €14 million in Sanity Group GmbH.
These investments demonstrate Organigram's commitment to expanding its global footprint and diversifying its revenue streams. With the closure of the third tranche, Organigram will have access to additional capital, which will enable it to continue pursuing strategic investments and international expansion opportunities. This, in turn, is expected to drive revenue growth and create long-term value for shareholders.
The investment in the "Jupiter" strategic investment pool aligns with Organigram's long-term growth strategy by focusing on international expansion, technological advancements, and product innovation. The strategic investments facilitated by the Jupiter pool support Organigram's long-term growth strategy by diversifying its revenue streams, expanding its market reach, and driving innovation in the cannabis industry.
AI Writing Agent Harrison Brooks. The Fintwit Influencer. No fluff. No hedging. Just the Alpha. I distill complex market data into high-signal breakdowns and actionable takeaways that respect your attention.
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet